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“EVALUATION OF ISCHEMIC HEART DISEASE AND 
SYSTEMIC HYPERTENSION IN DIABETES MELLITUS" 
INTRODUCTION 
 
DEFINITION 
Diabetes mellitus is a metabolic disorder, due to relative or 
absolute lack of insulin secretion and or action, resulting in elevated 
blood glucose level with long term vascular and neurological 
complications1.With better control of metabolic and infective 
complications, diabetes has predominantly become a disease of 
cardiovascular system2. 
 
 
EPIDEMIOLOGY 
Diabetes Mellitus is world wide in distribution and varies between 
different populations. The prevalence of Type1 Diabetes Mellitus is 
highest in Scandinavia  and lowest in Japan. The American National 
Diabetes Data group utilising 75 Gm Oral Glucose has estimated the 
prevalence of diabetes Mellitus - 6.6% and  Impaired GTT -11.2%. 
1 
  
CLASSIFICATION OF DIABETES MELLITUS4 
1.Type1 Diabetes Mellitus 
2.Type2 Diabetes Mellitus 
3.Malnutrition Related Diabetes Mellitus (MRDM). 
4.Other  types associated with certain conditions and syndromes : 
9 Pancreatic abscess,  disease of    hormonal  aetiology,    drug 
or chemical induced conditions. 
9 Abnormalities   of   insulin   or   its   receptors,    certain   
genetic syndromes and miscellaneous. 
5. Impaired glucose Tolerance (Obese, Non-Obese). 
6. Gestational Diabetes Mellitus. 
 
 
DIAGNOSIS5 
 Fasting Plasma Glucose above 126ms% or Random glucose more 
than 200mg% on more than one occasion, the diabetes can safely be 
made.  
2 
SYMPTOMS OF DIABETES MELLITUS 
Classical symptoms of diabetes are 'Polys' - (Polydipsia, Polyuria 
/Polyphagia). The other symptoms are weight loss, asthenia, pruritus 
vulvae or balanitis or presents with macro or microvascular 
complications. Myocardial ischemia or infarction may be silent, because 
of blunted appreciation of pain and most often atypical symptoms such as 
confusion. dyspnoea, fatiguability or nausea or resting tachycardia. Most 
of the patients are asymptomatic and found to be diabetic on routine 
examination.  
DIABETES AND CARDIOVASULAR DISEASE6 
The morbidity and mortality in diabetes is attributed predominantly 
to diabetic heart disease7.Coronary Artery Disease (CAD) is about twice 
as frequent in diabetic women compared to respective non-diabetics. One 
third of all deaths in DM patients after forty years of age has been 
attributed to CAD. 
CAD in diabetic patients is characterised by greater prevalence of 
triple vessel disease and diffuse8 coronary atherosclerosis as evidenced by 
post mortum  study and histological analysis. Linear arterial calcification 
has been found to correlate with the degree of glucose intolerance. In 
autopsies conducted in Type1 Diabetes Mellitus patients, the lumen of 
coronary vessel was reduced by half in about 50% of examined arteries 
compared to 1% in non-diabetics. 
3 
In fact 75% subjects sustaining acute myocardial infarction before 
45 years of age have some form of glucose intolerance. systemic   
hypertension acting   in   concert   with   Diabetes Mellitus   results in 
significant mortality and morbidity9. Blood Pressure has been found to be 
10-12 mm higher in diabetic subjects compared to the general population. 
Prevalence of hypertension is about 40-60% in Type2 Diabetes Mellitus 
patients10. 
 
The scenario of hypertension is different in Type1 Diabetes 
Mellitus and Type2 Diabetes Mellitus. Hypertension in Type1 Diabetes 
Mellitus often appears with onset of nephropathy while in Type2 Diabetes 
Mellitus 50% of patients are hypertensive at the time of diagnosis. 
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Aim of the Study 
 
AIM OF THE STUDY 
 
1. To study the incidence of both Ischemic Heart Disease and 
Systemic  Hypertension  in Diabetes Mellitus. 
2. Evaluating the age and sex  incidence of Systemic 
Hypertension  and Ischemic Heart Disease  in Diabetes 
Mellitus. 
3. Evaluating the risk factors involved  in causation of cardio 
vascular complications. 
4. To study the prevalence of Silent Myocardial Infarction and 
Ischemia in DM patients.  
5. To identify the maximum duration taken for the 
development of cardio vascular  complications in DM 
patients. 
5 
  
 
 
 
 
Review of Literature 
REVIEW OF LITERATURE 
DEVELOPMENT AND CONCEPT OF CARDIO-
DIABETOLOGY11 
 
With better control of metabolic and infective complications, 
diabetes has predominantly become a disease of the cardiovascular 
system. Cardio-Diabetology is emerging as a sub-speciality throughout 
the globe to tackle the menace of cardiac related mortality in diabetes, 
particularly Type2 Diabetes Mellitus 
 
Cardiac involvement in diabetes mellitus commonly manifests as 
CAD, which alone accounts for 40% of deaths in diabetes during 40's and 
this mounts to 50% in the sixth decade of life. About the age of 65 years, 
70% of diabetic patients of either sex die of cardiac involvement. 
 
CAD is the leading cause of mortality in Diabetes. It not only 
involves the epicardial coronary arteries but also the intramural coronary 
arteries. Silent ischaemic  events constitute a special feature of 
presentation. CAD in DM patients is not only frequent but occurs at 
younger age and the involvement is  more extensive. Triple vessel disease 
and the left main stem lesion are more common.  
 
6 
 Sudden cardiac death is the most dreadful complication and it is 1-
8 times more common in men and 3 times common in women compared 
to non-diabetics. CAD, Dilated cardiomyopathy and autonomic       
neuropathy contribute to this morbidity and mortality.  
 
Systemic Hypertension in diabetic patients is not un-common. The 
data from National Institute of Health USA shows that incidence of 
Hypertension is 2.8 times higher among diabetes below 45 years of age 
compared to the non-diabetics. Data from India is scanty and reveal 
varying prevalence of hypertension among diabetic patients. 
 
Recognition of Hypertension in Diabetes Mellitus is of crucial 
importance because it is a major risk factor for development of 
complications in Diabetic  patients12. It is also a great risk factor for the 
development of macrovascular disease. Diabetes Mellitus patients are 
more prone to develop coronary Heart disease especially when there is 
associated left ventricular Hypertrophy13. (Algorhythm1). 
7 
DIABETES RELATED HT14,15 
 
 
 
 
 
 
 Algorhythm - 1 
 
IN UTERO EVIDENCE16  
Low birth weight (Less than 2.5 Kg) is likely to predispose to the 
development of impaired glucose tolerance and Type2 Diabetes Mellitus 
at a later age. The low birth weight internalises adaptive metabolic 
process in-utero which, if subsequently followed by normal or abundant 
supply of food during childhood, adolescence and adult years, result in 
the development of IGT, Type2 Diabetes Mellitus, Hypertension and 
possibly dyslipidemias and coronary artery disease in the middle years of 
life. This was earlier called 'Double - Trouble-Syndrome'. These 
evidences were generated through the studies in U-K, Sweden, USA and 
some other parts of the world. Hertfordshire-Cohort study reveals that 
men with lowest birth weight at birth and at one year had the highest 
death rates from Ischemic Heart Disease. 
NEPHROPATHY 
ATHEROSCLEROTIC 
RENOVASCULAR 
DISEASE 
SYSTOLIC 
HYPERTENSION 
AUTONOMIC 
NEUROPATHY 
      8 
  
 
 
PATHOGENESIS OF CORONARY ARTERIAL HEART 
DISEASE IN DIABETES MELLITUS18 
I.IMPACT OF HYPERGLYCAEMIA AND HYPERINSULINEMIA 
Coronary heart disease occurs 3 times greater in frequency in 
patients with Type2 Diabetes Mellitus. Females lose their immunity 
against CHD when they have Type2 Diabetes Mellitus. Accelerated  
atherosclerosis causing macrovascluar diseases affecting coronary, 
cerebral or peripheral arteries, is the main cause of morbidity in patients 
with Diabetes Mellitus. The endothelial cells of the vessels bears the 
brunt of various pathogenic process leading on to vascular occlusion19 as 
shown in the table no:1. 
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S.No Particulars 
1. Endothelial injury with resultant increased permeability. 
2. Migration of various cells into the sub endothelial tissue 
3. Adherence of platelets to subendothelial collagen 
4. Migration of macrophages 
5. Smooth muscle cell proliferation and plaque formation 
6. Platelet aggregation leading to thrombogenesis 
7. Vascular occlusion 
 
CASCADE OF EVENTS LEADING TO ENDOTHELIAL INJURY 
TABLE NO: 1 
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    Hyperglycaemia is the hall mark of Diabetes Mellitus. It is responsible 
for all the complications in DM Patients. It leads on to the following 
biochemical changes. 
a) GLYCATION 
The non-enzymatic linkage between a reducing sugar and a 
receptive aminoacid, indeed widespread, affecting virtually every tissue 
protein. The most relevant proteins which involved in atherosclerosis are. 
 
I.Lipoprteins20  
Of the elevated lipoproteins  such as  total cholesterol, 
Triglycerides, low density lipoprotein (LDL) and very low density 
lipoprotein, glycation of LDL is seen in 3 or 4 times higher in diabetic 
patients. Apolipoproteins Al, Al l, B, C & E are also glycated to a greater 
extent21. LDL is deposited in the blood vessel wall which under go 
modification and degradation to form insoluble complexes are referred  as 
Advanced Glycation End products (AGE) with potential 
pathophysiological consequences. Normally, LDL is metabolished after 
recognition by the LDL receptors, but due to glycation of its lysine 
residue it interferes  with its recognition by LDL receptor and thus has to 
go through the alternative pathway of endocytosis by macrophages - thus 
forming foam cells which is characteristic of  the early atherosclerotic 
plaque  and  LDL & LP (a) plays a major role in atherosclerosis22.  
 11 
 2. Coagulation proteins 
Glycation of coagulation proteins particularly  antithrombin III and  
fibrin results in interference of the cleavage of fibrinogen. 
 
3.Structural proteins 
Collagen - most abundant proteins in the body which is rich in 
lysine, and most vulnerable to AGE formation due to glycation. The AGE 
formed on long lived collagen in the walls of blood vessels can trap LDL 
which will undergo AGE formation due to glycation results in 
atherosclerosis.  
 
b) Hyperglycemia and Intracellular Hypoxia23  
Hyperglycemia induces intracellular hypoxia due to increase in 
oxygen demand by the altered metabolic substrates and glycohemoglobin 
has greater affinity for oxygen. Hyperglycemia has its impact on 2-3 DPG 
in RBC which leads to tissue hypoxia. There is a rise in free cytoslic 
NADH / NAD ratio called Pseudohypoxia. This cellular hypoxia 
produces microangiopathy which may be responsible for damage to the 
media of large size arteries. 
 
 
 12 
HYPERINSULINEMIA24 
Excessive concentration of insulin might contribute to the 
development of atherosclerosis. Recent study demonstrates that sustained 
physiological Hyperinsulinemia commonly seen in fasting state in Type2 
Diabetes Mellitus or obesity, significantly alters the intracellular 
partitioning of glucose between oxidative & non-oxidative pathways. In 
muscle, glucose disposal is markedly reduced. This impairment of non-
oxidative glucose disposal contributes to insulin resistance. Recently it 
has been suggested by Michael stern et al that Type2 Diabetes Mellitus 
and CHD share common genetic and environmental factors. The 
consequence of inflammatory disease in response to oxidative insult is the 
Common soil for both the diseases.  
  
 Oxidative stress also forms a Common soil for Type2 Diabetes 
Mellitus / CHD forming oxygen free radicals which are toxic metabolites 
derived from refined cereals. Hyperglycemia and insulin resistance and 
hyperinsulinemia may be associated with increased production of oxygen 
free radicals glucose autooxidation and increased non-enzymatic 
glycation. Oxidative stress is also responsible for increased platelet 
reactivity and thromobogenesis. This newer concept of "Common soil" 
for both Type2 Diabetes Mellitus and CHD promise a simple therapeutic 
option for dietary intervention.   
     13 
 ii) IMPACT OF DYSLIPIDEMIA25 
 
The nexus between dyslipidemia and CAD in diabetic patients is 
overwhelming. An insight into this nexus is mandatory to understand this 
deadly complication. 
 
Current knowledge suggests the possible role of 
hypertriglceridemia, low levels of high density lipoprotein cholesterol as 
important risk factors. At present atherosclerotic vascular disease is the 
most common  complication of Diabetes Mellitus, particularly in women. 
Incidence of CAD has been found to  be 2 to  3   fold higher amongst 
patient with Diabetes Mellitus. Analysis  by Das. S, Mistra R.K, Jena et 
al, over the past three decades indicates progressive increase in the 
incidence of CAD as the cause of deaths. 
 
The genesis and progression of atherosclerotic lesion have been 
observed to be different in diabetic patients. Normally it is 'Type 1' or 
Rokintansky Type' lesion. But  in Diabetes Mellitus it is "Type 2' or 
'Virchow's Type' where the susceptibility for atherosclerotic vascular 
disease is  much greater.  
       14 
  Glycation of apoproteins, cell membrane proteins and proteins of  
membrana propria of the endothelium along with raised quantity of  
glucosaminoglycans and advanced glycation end products in Diabetes 
Mellitus enhances LDL,  VLDL. They bind the endothelial cells and 
accelerates the atherosclerosis.  Further the enzyme Lecithin - Cholesterol 
Acyl Transfarase (L-CAT) regulating conversion of free cholesterol to 
esterified - cholesterol in circulation as well as lipoprotein lipase (LPL) 
present at capillary endothelium. Insulin primes these enzymes and thus 
insulin resistance and insensitivity existing in the peripheral bed of Type2 
Diabetes Mellitus can dampen these process.   Suppression of   L-CAT 
activity will lead to lesser generation of HDL while slower action of LPL 
will produce delayed clearance of VLDL. 
 
In diabetes due to loss of endothelial electrical barriers, consequent 
to glycation of basement membrane protein, TG rich LPs get access to 
sub-endothelial layers and cause lipid ladening of smooth muscle cells - 
the key to atherogenesis. Diabetic subjects seen in India have high level 
of Triglycerides (TG). Raised TG with decreased HDL-c and normal or 
near normal TC and LDL is the usual lipid profile in diabetic patients. 
Raised TG even in the presence of normal TC and LDL-c is 
atherogenic.26 
 
       15 
 (iii) IMPACT OF DIET AND ANTIOXIDANTS27 
Diabetes is commonly associated with CAD because dyslipidemia, 
oxidative stress and hyper insulinemia are related to diet and life style. 
Obesity in Type2 Diabetes Mellitus increases the risk of CAD. Diet high 
in plant foods and low in fat are associated with a lower prevalence of 
Diabetes and CAD. Besides total and saturated fats and refined 
carbohydrates which adversely affects diabetes, the n6/n3 ratio of fatty 
acids and antioxidants are being increasingly   linked with 
atherosclerosis. 
 
 
Antioxidants Vitamins A, E and C, beta - carotene, dietary soluble 
fibre, starch foods, plant sterol, flavanoids polyphenols, and ubiquinone 
may have beneficial effect by decreasing oxidative stress28. Low fat 
cereal based diets are associated with low risk of Diabetes and CAD in 
rural population of India. Table 1 shows sources of free radicals in DM.  
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 SOURCES OF FREE RADICALS IN DIABETES 
 
Table - 1 
Free radical scavengers which limit hydroxyl radical by trapping 
reactive radicals in both hydrophilic and lipophilic cell membrane 
environments are vitamin C gluathione and uric acid and vitamin E and 
ubiquinol respectively. ubiquinol is a direct free radical scavenger as well 
as it also regenerates vitamin E after it converts into inactive 
tocopheroxyl form. Vitamin E is a highly potential antioxidant.   
S.No Particulars 
1. Non-enzymatic glycosylation of proteins 
2. Changes in the level of inflammatory mediators 
3. Monosaccharide auto – oxidation. 
4. Polyol pathway activity and alterations in sorbital pathyway 
activity 
5. Indirect production of free radicals through cell damage by other 
causes  
6. Reduced antioxidants reserve  
7. Metabolic stress due to change in energy metabolism. 
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 ANTIOXIDANT DEFENCES IN THE BODY 
Particulars  
Primary enzymatic defences Functional dependences 
Super oxide dismutase Zinc, Manganese 
Glutathione peroxidase Selenium 
Catalase Iron Copper 
Coenzyme Q (Ubiquinol) 
Secondary stabilizing substances 
 
Vitamin E Miscellaneous 
Vitamin C Albumin 
Vitamin A  Uric acid 
Beta – Carotene Transferrin  
Carnitine Ceruloplasmin 
 
In brief, eating 400 gm / day of fruits, vegetables and legumes and 
another 400 mg/day of cereals in conjunction with 25 gm/day of oils, 
increased physical activity (>300 K cal/d) and cessation of smoking may 
be protective in the primary prevention of diabetes and CAD. There is 
great evidence that as pancreatic betacells and arterial endo-thelial cells 
have low antioxidative enzyme activities, they might be more sensitive to 
free radical injury. 
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EVALUATION OF MYOCARDIAL ISCHEMIA 
Coronary artery disease (CAD) is common in diabetic patients, 
Besides epicardial coronary arteries, microcirculation is also involved. 
CAD is a common cause of premature morbidity and mortality in 
diabetics Evaluation of myocardial ischemia in them is always a key 
issue. Early detection is therefore paramount importance. In a Patient 
with known CAD, of the total ischemic episodes only 20-30% are 
symptomatic and the remaining 60-70% are silent known as Silent 
Myocardial Ischemia (SMI). Cl.nically CAD is evaluated by several tests 
besides meticulous history and physical examination. 
 
S.No Particulars 
1. Resting ECG 
2. Ambulatory ECG monitoring  
3. Stress test 
 a) Stress Electrocardiography29  
 b) Stress Echo 
 c) Pharmacological Stress Echo 
 d) Stress Thallium 
4. Coronary angiography30 
5. Intracoronary vascular ultrasound (selected cases)  
 19 
 1. Resting ECG 
In diabetic patients resting ECG is normal in approximately  half of 
the patients. The most common ECG abnormalities are non-specific ST-T 
change with or without evidence of prior MI. A normal ECG doesn't 
exclude the presence of CAD. Severe (Triple Vessel disease) 3º VD may 
exist with a normal resting ECG. 
 
A variety of conduction disturbances like left anterior fascicular  
block or LBBB may be seen in a asymptomatic diabetic patients. LVH on 
ECG may suggest associated hypertension.   Q wave or non Q MI may be 
seen in ECG as a silent findings. 
 
2. Ambulatory 24 hrs Electrocardiography (HOLTER'S) 
It is used to detect SMI or ventricular arrhythmias in diabetic 
patients with suspected or established CAD and myocardial ischemia. 
Cardiac autonomic neuropathy may mask anginal  episodes SMI and total 
Ischemic burden. 
              20 
 ECG SHOWING ANTEROLATERAL MYOCARDIAL 
INFARCTION 
 
Fig1 
 
 
 
 
 
 
 
  
                            LBBB WITH MI  
                                Fig 2 
 
 
 
 
 
 
3. Stress Test 
a) Stress Electro Cardiography: 
 
Tread Mill stress test or bicycle ergometric stress test is used as a 
screening test for CAD in symptomatic or asymptomatic diabetes. It is 
safe, simple and inexpensive. Tread mill exercise testing may suggest the 
presence of significant obstruction in one or more coronary arteries. It is   
66% negative in 1º VD (1 Vessel Disease). 33% negative in 2º VD. All 3º 
VD are virtually picked up by this test.  
 
The Tread mill test is useful particularly in 2-vessels and 3-vessels 
disease during exercise and recovery. The predictive value is high if 
typical chest pain occurs during the exercise with ST segmental 
depression - horizontal or downsloping of 1 or more than I mm. The early 
onset of ST segment depression during exercise testing in diabetes, its 
long persistence following discontinuation of exercise, a down sloping or 
horizontal depression and a low work capacity or duration of exercise are 
all strong indicators of multi vessel CAD with myocardial ischemia in 
diabetes. A negative result does not exclude CAD. However, the presence 
of three vessel or left main CAD is excluded in diabetic patients by 
negative test. 
              21 
b) STRESS ECHO CARDIOGRAPMY 
2 Dimension Echocardiography and Doppler echocardiography is 
very valuable, relatively inexpensive and has high sensitivity and 
specificity when performed immediately or during stress to detect LV 
regional wall motion abnormality and LV function. 
 
c) PHARMOCOLOGICAL STRESS ECHOCARDIOGRAPHY: 
Among diabetic patients unable to exercise, stress echo is done 
with Dobutamine or Dipyridamole. Dobutamine is prefered because of its 
biphasic response. Dobutamine is used in initial dose of 5 ugm / Kg / min. 
The dose is increased by 5ugm/Kg  every 3rd minute till a maximum dose 
of 40 u gm/Kg /mt used or target heart rate is achieved or an adverse 
reponse is seen. 
 
d) STRESS THALLIUM IMAGING 
In individuals with negative stress ECG and high suspicion of 
CAD, stress thallium imaging is performed.   The test has sensitivity of 
82% and specificity of 88%. 
              22 
  
45 years old male patient with acute mayocardial infarction and pulmonary edema 
 
 
                                       Fig 3 
 
 
 
 
 
 
 
 
 
  
            ECHO SHOWING  MITRAL REGURGITATION  AFTER MI 
Fig 4 
4.CINE CORONARY ANGIOGRAPHY 
i) Coronary Angiography31 
Definitive diagnosis of CAD, its precise assessment and anatomic 
severity requires coronary angiography. This test is very valuable, 
definitive and essential when stress test is positive and or left ventricular 
function is impaired clinically or non invasively. This helps in planning 
suitable revascularization in patients with ischemia. The diameter of 
stenosed vessel in angiography in DM patients have a significantly 
smaller luminal diameter in Infarct Related Artery than in non - DM 
patients.  
 
The angiographic restenosis rate following PTCA reported in 
National Heart, Lung, Blood Institute Angioplasty Registry is 49% to 
71% in diabetics. Newer devices like DCA stenting and excimer laser 
angioplasty have failed to reduce restenosis32. Re-occlusion rates 
following lytic therapy also higher than in non-diabetics33. 
 
ii) Intracoronary Vascular Ultrasound (IVUS) 34 
In selected cases of CAD where there is controversy regarding 
severity of atherosclerotic obstruction on coronary angiography, the 
coronary artery patho-anatomy is evaluated with Intracoronary Vascular 
Ultrasound. 
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CORONARY ANGIOGRAM AND SCHEMATIC DIAGRAM SHOWING BLOCK IN LEFT 
ANTERIOR DESCENDING ARTERY 
 
 
Fig 5 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coronary angiography no doubt remains the modality of choice for 
rapid visualisation of the entire coronary tree.  However, it should be 
realised that it only exhibits luminal narrowing as a two-dimensional 
silhouette of a three-dimensional structure,   Intracoronary Vascular 
Ultrasound is utilised to unmask atheromatous disease not properly 
visualised  or missed by coronary angiography. IVUS although is not 
widely available, it is the modality of choice to judge the adequacy of 
coronary interventions. 
 
IVUS is capable of providing high resolution cross-sectional 
images of normal and abnormal arterial architecture, atheromatous 
plaques and its complications    and    is    radically    changing   the   
diagnosis    and  interventional management of coronary artery disease35.  
 
Advantages of IVUS 
S.No Particulars 
1. Superb display of circumferential extent of atheroma. 
2. 
Unmasks atheromatous disease not visualized by coronary 
angiography   
3. Visualization of plaque, its distribution and morphology,  
4. Demonstrates presence of dissection, intimal flaps 
5. Judges adequacy of coronary interventions in a better way. 
              24 
ACUTE MYOCARDIAL INFARCTION IN DIABETES 
MELLITUS35 
 The clinical presentation and course of AMI in DM are different. 
36AMI occurs earlier in diabetic patients, and has higher incidence of 
silent infarct and pump failure. Relative risk of myocardial Infarction is 
50%37 greater in diabetic men, 15% greater in diabetic women. 
38Sudden death 50% more often in diabetic men. 300% more often 
in diabetic women. 30% of death in diabetics are as a result of AMI. 
Increased platelet aggregation due to synthesis of thromboxane A2 in 
high amounts in poorly controlled diabetes mellitus and vascular spasm 
which leads on to thrombus formation in vessels with its sequelae. Since 
platelet aggregability is high through out the day – MI39 occur at any 
time.  
SILENT MYOCARDIAL INFARCTION: 40 
Ischemic chest pain is blunted in Diabetes Mellitus. Myocardial 
ischemia or infarction  may be associated with mild symptoms or totally 
absent. During Tread Mill exercise test, angina is absent due to severe 
autonomic neuropathy. Atypical symptoms like dyspnoea, fatique, 
nausea, vomiting or confusion which are attributed to metabolic 
disturbances leading to delay in the diagnosis.  Periinfarction mortality is 
high. 
                         25 
COMPLICATIONS OF MYOCARDIAL INFARCTION IN  
DIABETES MELLITUS 
Diabetic patients develop complications more often and mortality 
may be high. These include cardiogenic shock, CHF, conduction 
disturbances, etc. Anterior wall infarction is more common. On occasion 
Left41 Ventricular Free wall rupture may be the presenting feature.   
Reinfarction is higher. Early   introduction   of  Aspirin,   thrombolytics   
and Beta Blockers   reduces mortailtiy42,43. Coronary artery Disease is the 
most common cause of death in Diabetes Mellitus Patients. 44,45  
HYPERTENSION  IN DIABETES MELLITUS 
EPIDEMIOLOGY 
 
Diabetes and hypertension Co-exist three times more commonly, 
strongly predispose the individual to atherosclerotic cardiovascular 
disease. Essential hypertension with Type2 Diabetes Mellitus constitute 
over 90%. Diabetic nephropathy which occurs after 15 years of diagnosis 
of diabetes is one third of those with Type1 Diabetes Mellitus and 20% of 
those with Type2 Diabetes Mellitus. Isolated systolic hypertension is 
observed more commonly in diabetics and supine hypertension with 
orthostatic hypotension observed in diabetics with autonomic 
neuropathy47. Type1 Diabetes Mellitus patients are usually normotensive 
until overt renal disease develops. 
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ETIOLOGY 
Hypertension in diabetic patients can be classified into four 
different heads. 
 
a. Renal hypertension with diabetic renal disease. 
Type1 Diabetes Mellitus patients are usually normotensive until 
overt renal disease develops. In Type2 Diabetes Mellitus, hypertension 
increases markedly even before the proteinuric state. Micro albuminuria  
is the first sign of diabetic renal disease. 
 
b. Hypertension without renal disease 
Factors that contribute to the development of this type of 
hypertension are genetic, obesity, glucose intolerance, hyperinsulinemia 
etc. Insulin causes reabsorption of sodium from distal part of nephron and 
has antidiuretic effect. 
 
c. Systolic Hypertension 
Isolated systolic hypertension may be defined as a systolic BP of 
140 mm of Hg or more with normal and low diastolic pressure. In 
diabetic patients with atherosclerosis, large arteries loose their elasticity 
and gradually become rigid and all blood ejected from the left ventricle 
will enter this arterial system which is incapable of expansion, thus 
systolic pressure will be increased. 
              27 
 d. Orthostatic Hypotension 
Baroreceptor reflexes which are important in maintaining blood 
pressure are often blunted in patients with diabetic neuropathy. Other 
mechanisms include loss of proteins in urine causing contraction of 
plasma volume and decreased myocardial contractility and decreased 
cardiac output.  
 
PATHOGENESIS 
 The genesis of hypertension in diabetes mellitus include renal 
disease, hyperinsulinism, atherosclerosis, genetic etc. The role of genetic 
predisposition is suggested by the fact that history of hypertension is four 
times more frequent in patients of Type1 Diabetes Mellitus with 
nephropathy than those without nephropathy. An increase of Sodium / 
Lithium counter transport by the red blood cells is considered a marker 
for essential hypertension49. Proposed mechanisms by which insulin 
resistance and or hyper insulinemia may lead lo hypertension  in obese 
patients are. 50 
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1. Enhanced renal sodium and water reabsorption. 
2. Incrased salt intake and salt sensitivity. 
3. Augmentation of the pressor and aldosterone response to 
angiotensin II. 
4. Changes in Trans membrane electrolyte transport, increased 
intracellular sodium and Ca accumulation. Decreased Na+, K+ - 
ATP ease activity. 
5. Stimulation of sympathetic nervous activity. 
6. Reduced synthesis of vasodilator prostaglandins. 
7. Impaired vasodilatation. 
8. Increased secretion of endothelin. 
 
 The relation between hypertension, diabetes and obesity 
predominantly in the  upper  body,   composing  the  major components  
of the  insulin  resistance 'Syndrome X' is shown in the following 
algorhythm. 
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SYNDROME X51 
HYPERTRIGLYCERIDEMIA 
 
LIPOLYSIS 
OBSESITY + 
ANDROGEN 
INCREASED  
ABDOMINAL FAT  
RELEASE OF FREE 
FATTY ACIDS 
TYPE OF 
DIABETES MELLTTUS 
PERIPHERAL  
INSULIN 
RESISTANCE 
INCREASED  
PANCREATIC 
INSULIN 
SECRETION  
DECREASED 
HEPATIC INSULIN 
EXTRACTION 
HYPERINSULINEMIA 
INCREASED 
SYMPATHETIC 
NERVOUS ACTIVITY  
SODIUM 
RETENTION 
VASCULAR  
HYPERTROPHY
HYPER TENSION 
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  Atherosclerosis is premature, more extensive and has accelerated 
progression associated with abnormalities of lipid metabolism because of 
lack of insulin   which lead on to  faulty LDL, receptor and accumulation 
of LDL.  This LDL gets transported subendothelialy resulting in lipid per 
oxidation and  circulating T- lymphocytes and monocytes adhere to 
vascular endothelium. These cells take up lipids and lipoproteins thus 
becoming foam cells forming fatty streaks projecting into the lumen of 
blood vessels. Hyperglycaemia increases endothelin secretion which is a 
powerful vasoconstrictor and mitogenic factor, while production of 
Nitrous oxide is diminished (a vascular smooth muscle relaxant, 
antimitogenic which inhibits platelet adhesiveness). Thus smoking,     
insulin     resistance,     hyperlipidemia     and     genetic predisposition, 
accelerates atherogenesis and hypertension occurs early in diabetes. 
 
MEDICAL THERAPY 
1. DIET52 
Dietary fats and antioxidants have significant role in modulating 
insulin  action and secretion.   Faulty nutrition  of the  present day  urban  
society present epidemic Type2 Diabetes Mellitus and CAD. 
Preservatives and pesticides in processed foods add there own quota of 
oxygen free radicals (OFR). 
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 Unsaturated fatty acids of both n6 and n3 in their physiological 
disproportion with high n6 / n3 ratio promote a variety of immune 
inflammatory disorders including Diabetes Mellitus and atherosclerosis. 
 
Guidelines for diet: 53 
1. Slow weight reduction of about 2 Kg /month can be achieved with 
a reduced calorie intake of about 20 Kcal/Kg. 
2. Importance of fish in the diet to have 5 or more helpings (each 30 
gms) a week. 
3. To avoid increased availability of arachidonic acid avoid other 
animal foods. 
4. Fresh fruits 2 – 3 helpings of vegetables at each meal. Almost all 
vegetables and pulses can be taken. Avoid simple sugars, refined 
cereals and bakery products. 
5. Alcohol to be avoided. 
6. Saccharin can be used in small quantity. 
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 2. ALCOHOL53a 
Alcohol in small amounts (less than two units, a unit is 9 Gin- 
equal to 1/2 pint of beer or 8 Gm of wine or 30 ml of spirit) a day called 
Sensible Drinking is believed to provide protection from coronary 
mortality and atherosclerosis, but in large amounts increases blood 
pressure and excess cardiac events. This is known as 'U' 'J' or 'J'; shaped 
response. 
 
 
3. DYSLIPIDEMIA 
When   diabetes   and   dyslipidemia   occurs   in   combination,   
the   risk  is significantly increased in Type2 Diabetes Mellitus patients, 
whereas insulin therapy corrects lipid  abnormalities in Type2 Diabetes 
Mellitus patients. 
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 Management of dyslipidemia in Type2 DIABETES MELLITUS with 
CAD is by step care approach. 
Step 1 Non pharmacologial measure 
Diet therapy 
• energy restriction 
• composition  
• cessation of smoking, reduction of alcohol   
             intake, increased  physical activity 
• aerobic excercise, brisk walking, swimming.  
       bicycling,  yoga etc 
Step II Hypoglycemic drugs 
• Sulfonylurea 
• Biguanides 
• Insulin 
• Antioxidants – Vitamin C, - Carotine, Vitamin  
       E. 
Step III Lipid lowering drugs 
• Statins 
• Bile acid sequestrants 
• Nicotinic acid 
• Probucol 
• Estrogens 
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Although conventionally non - pharmacological treatment in 
conjunction with good glycemic control is usually tried for 3-6 months 
for managing dyslipidemia in diabetes, in CAD with malignant 
progression, drug therapy should be started concurrently. 
 
CURRENT RECOMMENDATIONS FOR DESIRED 
LEVEL OF CHOLESTEROL:55 
 
Primary 
Prevention 
Secondary 
Prevention 
Lipid Determination Desirable  Desirable 
Total Cholesterol < 200 mg/dl  
LDL Cholesterol 
Among Indian 
<130 mg/ dl 
<100 mg/dl 
<100gm/dl 
<80 mg/dl 
HDL Cholesterol >40 mg/dl >40 mg/dl 
TC/HDL –C Ratio <4.5 <3.5 
LDL-C/HDL-C Ratio <3 <2.5 
Triglyceride <150 mg/dl <150 mg/dl56 
 
Hypertension is frequently associated with diabetes. The drugs 
which have an adverse effect on lipids should be avoided. ACE 
inhibitors, calcium channel blockers and alpha-1 antagoinst can be used 
as they are lipid friendly and do not cause carbohydrate intolerance. 
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4.Anti Diabetic Drugs 
 The bulk of CHD in diabetic patients belongs to Type2 Diabetes 
Mellitus and it is in this subject, the choice of drug may vary from one 
drug to another or to a combination of drugs. In MRDM and FCPD 
patients the choice to antidiabetic drug is limited to insulin only. In Type2 
Diabetes Mellitus  the choice of drugs may vary. The specific steps in the 
management of CHD are practically similar for subjects with or without 
diabetes. The second generation agent gliclazide has been described to 
have special properties for prevention of atherosclerosis and the sequlae 
by some other mechanisms in addition to control of hyper glyemia. So it 
is considered more suitable for use in elderly with or without CHD. 
 
 The novel Sulfonylurea agent Glimipride57 – its action on cardiac 
myocytes and coronary vasculature is very much lower than others and 
acts by combining with a different  protein at a portion of the receptor 
different from other SU compounds . It has antiatherogenic and anti-
thrombotic properties. Biguanides are specially suited for obese patients 
with CHD without hepatic or renal dysfunction or cardiorespiratory 
insufficiency. The antiatherogenic effect and favourable action on 
haemorrheology further adds to their utility in CHD. Metformin is 
preferred. 
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 Insulin is the preferred agent in Type2diabetes Mellitus with AMI 
and also in post MI state. Hyperglycemia is controlled by low dose 
insulin infusion with regular .blood glucose monitoring so as to maintain 
the levels between 100-150 mg/dl. So diabetes mellitus should be under 
treated as hypoglycemia is worser than hyperglycemia58.Alpha 
glucosidase inhibitors and soluble fibres are suitable for use particularly 
in overweight patients with high post-prandial plasma glucose. 
Thiazolidinediones  lower insulin resistance and hence may be suitable 
for use in diabetic patients with CHD.  
 
Control should be achieved with low to moderate doses or else 
combination have to be taken. Insulin should be started when fasting 
plasma glucose is above 15 mmol/L and in very lean patients.  Any anti 
hypertensive can be used. But  Beta blockers are usually avoided because 
it decreases the release of insulin and masks the symptoms and signs of 
hypoglycaemia. ACE inhibitors are more preferred. It can prevent 
development of nephropathy and control hypertension. 
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INTERVENTIONAL  TREATMENT  
1. Catheter interventions59 
Catheter interventions like angioplasty, intracoronary stents and 
others are being done in diabetes mellitus patients with CAD. Restenosis 
is higher in insulin requiring patients and they have reduced long term 
survival. Both PTCA and CABG have same long terms survival with 
poor outcome after bypass surgery.  
 
2. Surgical revascularization60,61 
"With technological advances and refinements in techniques of 
surgery, the presence of a diabetic state does not come in the way for 
providing benefit of surgical revascularization. Present day 
revascularization procedures include. 
(i) Conventional CABG through mid sternotomy approach62. 
This may be performed by using 
a) Saphenous vein graft 
b) Internal mammary artery 
c) Total arterial revascularization using IMA, Radial, Gastroepiploic 
or inferior epigastric artery.  
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 (ii) Transmyocardial Lazer revascularization (TMLR). 
In this procedure vascular channels are created from left ventricular 
cavity directly into the myocardium (based on anatomy of reptilian heart). 
Frequent indication for this procedure is refractory angina where PTCA 
or by pass surgery is not allowed. TMLR can be combined with CABG in 
patients in whom by-pass surgery cannot be performed for all area 
because of prevalence of diffuse coronary artery disease is higher on 
diabetics. This procedure is well tolerated in diabetic patients and showed 
no significant adverse outcome compared to non-diabetics. 
 
 
(iii) Minimally invasive direct coronary artery bypass (MIDCAB) 
This technique performed with small invasion and without 
cardiopulmonary bypass, and has dramatically changed the surgical 
management of coronary artery disease. 
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 RISK FACTORS IN DIABETES MELLITUS 
Obesity: 
 Obesity is defined as Body Mass Index of ≥  30. All  the patients 
were classified according to their BMI 
Classification BMI 
Underweight <18.50 
Normal 18.50 – 24.99 
Overweight > 25.00 
Pre-obese 25.00-29.99 
Obese Class – I 30.00 – 34.99 
Obese Class – II 35.00 – 39.99 
Obese Class – III > 40.00 
 
Family History: 
 Family History is recorded as a risk if there is a  history of 
coronary artery disease in Male first – degree relative of <55yrs or in 
female first-degree relative if <65 yrs. 
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Dyslipidemia: 
 
Dyslipidemia is defined as LDL cholesterol level of > 100 mg/dl 
(or) HDL cholesterol <40mg/dl (or) non-HDL Cholersterol > 130 mg/dl. 
Non-HDL Cholesterol = Total Cholesterol – HDL Cholesterol. 
 
Smoking  History:  
Patients were recognized as a non-smoker if they never smoked or 
they gave up smoking > 15 years back, an ex-smoker if they stopped 
smoking for > 3 months, and as a Current smoker if they still smoked 
within last 3 months. (After 15 years of cessation, the risk of a new 
Myocardial Infarction in former smokers is similar to that for those who 
have never smoked)  
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Materials and Methods  
 
MATERIALS AND METHODS 
SELECTION OF PATIENTS 
 
100 diabetes mellitus patients who attended CMCH for 
Hypertension and Ischemic heart disease in ICU and medical wards were 
included in this study over a period of one year. All the patients were 
subjected to detailed careful clinical examination and  laboratory 
investigations to assess cardio vascular status. 
 
 
METHODS OF EXAMINATION 
Detailed clinical examination including JVP, pulse, position and 
characters of cardiac apical impulse was done with an enquiry about the 
risk factors. BP was recorded in supine, standing and sitting positions in 
both upper and lower limbs. The heart was auscultated for abnormal S3, 
S4 and gallop rhythm. Fundus examination was done for changes of 
hypertension & diabetes. The respiratory system was examined for any 
adventitious sounds. Abdomen  was examined  for organomegaly,  
evidence  of free  fluid  and bruit. Central nervous system was examined 
for any neurological defecit.  
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 Body mass index was calculated from the formula (weight in 
kilogram / height in meter'.) 
BMI  = 2minHt
KginWeight  
 
The following investigations were done. 
1. Urine for albumin, sugar, deposits & acetone. 
2. Blood sugar & urea. 
3. Serum - Creatinine, cholesterol and electrolytes. 
4. Lipid profile - Total cholesterol, LDL, HDL, VLDL,, TG. 
5. X – Ray chest PA view 
6. ECG 
7. Echo cardiogram 
 
CRITERIA FOR DIAGNOSIS 
1. Diabetes mellitus 
The criteria proposed by the American Diabetes  Association  was 
followed for the study. 
a. Unequivocal elevation of plasma glucose concentration together 
with the classical  symptoms of diabetes such  as polyphagia,   polydipsia 
and weight loss. 
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b. Criteria for Diagnosis of DM: 
1. Symptoms of DM plus Random Blood Sugar Concentration ≥  
200mg/dl.     (or) 
2. Fasting Plasma Glucose > 126mg/dl   (or)  
3. 2hrs plasma glucose ≥  200mg/dl during an oral glucose 
tolerance test.  
 
2. Ischemic Heart Disease: 
a. History : 
Typical - with pain or discomfort localised in the upper or mid 
sternal region and appearing on effort. Pain may radiate to the jaws, 
shoulders, or arms on one or both sides with crushing or constricting in 
character compels the patient to halt all activity. Atypical - asymptomatic 
or is characterised by symptoms such as severe breathlessness, profound 
weakness, sudden loss of consciousness or acute pulmonary oedema. 
 
b. ECG Changes 
i. Ischaemia : ST segment depression of I mm from the J point with or 
without inversion of T wave. 
ii. lnfarction: Q-wave infarction - presence of pathological Q wave depth 
is more than 25% of the corresponding R wave and width is more than 
0.04 sec, with ST segment elevation and T wave inversion. 
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Non. Q wave infarction: 
Anatomic Zone ECG Zone 
1. Inferior wall II, III & a VF 
2. Anteroseptal wall VI to V4 
3. Extensive anterior wall I, aVL, VI to V6 
4. Apicolateral I, a VL, V4 to V6 
 
 
Hypertension 
If the blood pressure is more than 140/90 mm of Hg for three 
consecutive visits  is diagnostic of systemic hypertension. 
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Data Analysisof Results 
 
 
 ANALYSIS OF RESULTS 
The data collected out of the 100 patients there were 73 males and 
27 females. 
The Observations are as follows: 
1.   Number   of  patients   with   Ischaemic   heart   disease,   including   
myocardial infarction.  
 Total no of IHD patients                =       57 
          Ischaemic patients -31 (54.3%), Infarction patients - 26 (45.6%) 
Both ischemia and infarctions -7. 
        Silent ischemia -:9 (29.03%), Silent infarction - 11    (42.3%) 
2. Number of patients with hypertension without 
 associated coronary ischemic heart disease    = 21 
3. DM patients without IHD / SHT      = 22     
4. Number of patients with both systemic hypertension 
 and ischemic heart disease in Diabetes Mellitus      = 33 
5. The largest number of Ischaemic Heart Disease 6-10 years  
 after the onset of DM is       =  23  
6. The 'risk factors' such as smoking, alcoholism,  
 hypertriglyceridemia and family history contribute  
 maximum for development of IHD  and Systemic  
Hypertension  in Diabetes Mellitus i.e    = 62 % 
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VARIOUS TYPES OF CARDIOVASCULAR 
COMPLICATIONS IN 
DIABETES MELLITUS 
S.No 
Total No. of  
Diabetic 
patients 
studied 
Type of 
Cardiovascular 
disease 
No. of patients 
affected by the 
disease 
Percentage 
1. 100 No IHD 22 22 
2. 100 SHT Only 21 21 
3. 100 IHD Only 24 24 
4. 100 SHT + IHD 33 33 
5. 100 Total IHD 57 57 
6. 100 Total SHT 54 54 
 
As shown in the table No. 1 
9 In the present study, 57% have IHD. 
9 54 % have systemic hypertension. 
9 33 % have both hypertension and ischemic heart disease. 
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INCIDENCE OF ISCHEMIC HEART DISEASE 
AGE & SEX WISE 
Sex 
S.No Age in years 
Male Female 
Total Percentage
1 40-50 6 2 8 14.03 
2 51-60 16 3 19 33.33 
3 61-70 15 3 18 31.57 
4 Above 11 1 12 21.05 
  48 9 57  
 
 
INCIDENCE OF ISCHEMIA AND INFARCTION 
S.No Type of Lesion No.of Patients Percentage 
1 Ischemia 31 54.3 
2 Infarction 26 45.6 
3 
Both Ischemia and 
Infarction 
7 12.28 
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INCIDENCE OF SYSTEMIC HYPERTENSION AGE AND SEXWISE
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INCIDENCE OF SYSTEMIC  HYPERTENSION 
AGE AND SEXWISE 
Age in years Sex Total Percentage 
 MALE FEMALE   
40-50 5 3 8 14.81 
51-60 20 5 25 46.29 
61-70 11 4 15 27.77 
Above 70 5 1 6 11.11 
 41 13 54  
  
 The largest number of systemic HT were in the age group of 51 – 
60 yrs, i.e., 25 cases (46.29%). The maximum sufferers are males 41 
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 INCIDENCE OF ISCHEMIC HEART DISEASE 
AND SYSTEMIC HYPERTENSION 
Age in years Sex Total Percentage 
 Male female   
40-50 4 2 6 18.18 
51-60 12 3 15 45.45 
61-70 6 1 7 21.21 
Above 70 4 1 5 15.15 
 26 7 33  
 
 The incidence of combined  Ischemic Heart Disease & Systemic 
Hypertension  is in the age group of 51-60 years  (ie) 45.45% closely 
followed by 61-70 yrs(ie) 21.21%  
 Males have more incidence of IHD and SHD than Females. 
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CORRELATION BETWEEN DURATION OF DM AND INCIDENCE OF IHD
29.82%
40.35%
8.77%
12.28%
8.77%
Less than 5
6 to 10
11 to 15
16 to 20
>20
 
CORRELATION BETWEEN DURATION OF DIABETES 
MELLITUS 
AND INCIDENCE OF ISCHEMIC HEART DISEASE 
S.No 
Duration of 
Diabetes Mellitus In 
Years 
No. of Cases of 
Ischemic Heart 
Disease 
Percentage 
1 Less than 5 17 29.82 
2 6-10 23 40.35 
3 11-15 5 8.77 
4 16-20 7 12.28 
5 >20 5 8.77 
 
 The incidence of IHD is maximum, 6 – 10 yrs after the onset of 
DM. It is about 40.35% 
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Discussion 
DISCUSSION 
Cardiac involvement in diabetes commonly manifest as coronary 
artery disease (CAD),  which alone accounts for the majority  of mortality 
in diabetes.  
a. Prevalence of IHD in Diabetes in our study is 54.3%, whereas in 
other studies are as follows.   
Palhaniaand Sactar  -21.8% 
 Sterns ei.-tal     - 37.00% 
Brady V Biyfoglee      - 40% 
Lind back     - 63% 
 Several studies in India indicates       7 -14%. 
 
The discrepancy in the incidence of Ischemic Heart Disease among 
diabetes may be explained as follows : 
 
(i) different criteria adopted among various authors to diagnose 
Ischemic Heart Disease, ii) Presence or absence of various associated risk 
factors such as hypertension, Hyperlipidemia, obesity, cigarette smoking, 
alcoholism and Type 'A', personality. 
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The high incidence of Ischemic Heart Disease in the present study 
may be attributed to fast changing lifestyle adopted by the local 
population and the prevalence of risk factors in the subjects analysed 
(i.e.) 62%, having one or the other combined risk factors, which plays an 
important role in paving for the cardio vascular complications. In our 
study very advanced diagnostic methods such as coronary angiography 
gives an overall prevalence of CAD as high as 54.3%.  
 
The relative risk of myocardial infarction is 50% greater in diabetic 
men and 15% greater in diabetic women as substantiated by G.S. 
Sainnani & Rajesh Samani65 which correlates with the present study 
incidence of infarction of 45.6%. 
 
In most of the patients, ischemia and infarction co-exist, it is 
mainly due to the silent ischemia, pain of which is blunted in Diabetes 
Mellitus, but infarction some how brings  the patient to hospital and the 
infarction is being diagnosed. 
 
Silent ischemia is more common in Diabetes Mellitus. As per 
literature it is 60-70%. In the present study it is 30 %. Silent ischemia is 
more common in patients with family History of diabetes. Those who 
smoke cigarettes also develop silent ischemia. Myocardial infarction is 
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also presented with more of complications and peculiar presentations 
such as atypical character, location, acute breathlessness due to left 
ventricular failure and some others presented with arrhythmias or 
hypertension without chest pain. In the present study death due to 
myocardial infarction is more common in female patients than in male. 
The percentage is 23% in female and 15% in males It correlates with the 
Framingham heart study. Bundle Branch Block is very common 
presenting arrhythmia in this study group. There were 7 cases in women 3 
cases in men.  
 
b. Prevalence of Systemic Hypertension : 
 In our study prevalence of SHT is 21%. Prevalence of hypertension 
is 20% in U.S. urban population. R.Gupta epidemiological evolution and 
rise CAD in India - Published in South Asian .J. of Preventive 
Cardiology66 1997 reveals an urban incidence of Systemic Hypertension  
of 29.5%. 
 
 
The incidence of raised blood pressure is generally correlated with 
obesity, sedentary life style as in advanced age of  Type2 Diabetes 
Mellitus. In the present study also, the incidence of SHT in Diabetes 
Mellitus is well correlated with obesity and the other risk factors. The 
incidence of hypertension in the age group of 51-60 yrs is 46.29%. 
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C. Association of Systemic Hypertension  and Diabetes 
Mellitus 
An association between Systemic Hypertension  and Ischemic 
Heart Disease is well established. It is related to the underlying 
development of atherosclerosis which is firmly associated with incidence 
of both systemic hypertension and ischemic heart disease. 
 
In Framingham study, the risk of Ischemic Heart Disease especially 
myocardial infarction was found to be influenced by both systolic and 
diastolic pressure. Even elevated systolic pressure increases the risk in 
contrast with the views that diastolic pressure is more important as a risk 
factor for Ischemic Heart Disease. 
d. Analysis of Age incidence: 
Ageing plays important role in modifying the incidence of 
Ischemic Heart Disease & Systemic Hypertension  in all, particularly in 
Type2 Diabetes Mellitus. The prime pathogenesis behind development of 
Ischemic Heart Disease and SHT is atherosclerosis of vessels, which is 
more diffuse and prevalent in diabetes due to dyslipidemia. As the age 
advances, the incidence of atherosclerosis also  progress  leading on to 
the occlusion of blood vessels macrovascular lesion and increased 
incidence of Ischemic Heart Disease and Systemic Hypertension . 
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In the present study the incidence of lHD & Systemic Hypertension  
is more in the age group of 5 1-60 years of 33.33 % in the former and 
47.27 % in the later. Malhothra et al observes the peak incidence of 
36.3% in the sixth decade and Vishnava et al observed a peak incidence 
of 36.3% in the sixth decade66. 
 
E. Correlation between the duration of diabetes and ischaemic 
heart disease. 
 In the present study the incidence of ischaemic heart disease is 
more during the 6-10 years after development of Diabetes Mellitus - the 
percentage is 40.35%. 
 
 Many workers believe that the incidence of Ischemic Heart Disease 
is well correlated with the duration of the diabetes, [Bradly & Bryfogle], 
Abukhatave and Lewis did not observe any increase in the incidence of 
Ischemic Heart Disease in proportion to the increase in the duration of the 
diabetic status. Banerjee Patrak and Vaishnava et al observed as 
increasing trend of Ischemic Heart Disease incidence when  the diabetes 
was of more than five years duration. 
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Conclusion 
  
 
                    CONCLUSION 
 
¾ Diabetes mellitus plays an important role in the development and 
progression of Ischemic Heart Disease.  
¾ Ischemic Heart Disease is the most common cause of morbidity 
and mortality in diabetes patients.  
¾ Next to IHD, Hypertension plays an important role in the 
progression of diabetic complications and mortality.  
¾ Because of autonomic neuropathy, silent ischaemia and infarctions 
are more common in DM. This also accounts for the higher 
incidence of IHD mortality in DM.  
¾ Various risk factors like smoking, alcoholism, 
hypertriglyceridemia and family History all accelerates 
cardiovascular complications.  
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Appendix 
  
 
 
 
 
 
Proforma 
 
 
PROFORMA 
 
 
NAME:      AGE:   SEX: M/F  
I.P.NO:    DOA:   DOD: 
  
C/O:         
  
 CHEST PAIN-TYPE, RADIATION 
 SWEATING 
 PALPITATION 
 SYNCOPE 
 DYSPNOEA 
 PND, ORTHOPNOEA 
 GIDDINESS 
 NAUSEA & VOMITING 
 
 
HOPI: 
 
 
RISK FACTORS:  
DM/HT/SMOKING 
 
DIET:  
VEG/NONVEG/MIXED 
 
FAMILY HISTORY: 
 
IHD/OBESITY/DIABETES/HYPERTENSION/ 
HYPERLIPIDEMIA      
                
TREATMENT HISTORY:  
    DRUG INTAKE 
 
MARITAL HISTORY 
GENERAL EXAMINATION:  
 OBESITY 
 DYSPNOEA 
 CYANOSIS 
 CLUBBING 
 PITTING PEDAL EDEMA 
 XANTHALESMA 
 TENDON XANTHOMAS 
 ARCUS SENILIS 
 PULSE 
 BLOOD PRESSURE 
 
 
BP: 
HEIGHT:   WEIGHT:   BMI:  
 
CARDIOVASCULAR SYSTEM 
 
 APICAL IMPULSE  S1  S2  S3  S4 
 
 PERICARDIAL RUB   
 
RESPIRATORY SYSYEM: 
 
ABDOMEN: 
 
 
CENTRAL NERVOUS SYSTEM: 
INVESTIGATION: 
LIPID PROFILE:- 
TOTAL CHOLESTEROL:  mg% 
TGL:      mg% HDL:  mg% LDL: mg% 
ELECTROCARDIOGRAM: 
 
ECHOCARDIOGRAM: 
 
CHEST X-RAY 
URINE ROUTINE 
BLOOD SUGAR  
BLOOD UREA 
SERUM CREATININE 
 
 
 
 
 
 
 
  
ABBREVIATIONS IN MASTER CHART 
 
CM - Cardiomegaly 
HK - Hypokinesia 
DCM - Dilated Cardiomyopathy 
EF - Ejection Fraction 
LVH - Left Ventricular Hypertrophy 
TMT - Tread Mill Test 
MI - Myocardial Infarction 
N - Normal 
+ - Present  
- - Absent  
M - Male 
F - Female 
T - T wave Inversion  
 
 
 
 
 
 
